Ikena Oncology
Boston
About Ikena Oncology
Ikena Oncology discovers and develops biomarker-driven therapies for cancer patients. The company focuses on developing novel cancer therapies that drive the formation and spread of cancer. Ikena Oncology provides medical needs by discovering chemistry, translational science, and patient-centric drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $209.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (May 2023)
- Ticker: nasdaq:IKNA
- Website: ikenaoncology.com
- Phone: +1 857 273 8343
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ikena-oncology-85684 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.